15 Best Biotech Stocks to Buy According to Billionaires
In this article, we will be taking a look at the 15 best biotech stocks to buy according to billionaires. Although biotech ...
Alzamend Neuro files to sell 75.775M shares of common stock for holders
The company is not selling any shares of its common stock under this prospectus and will not receive any of the proceeds from the sale of the ...
FMIBlog2d
Global Anti-Neurofilament L Antibody Market Poised for Significant Growth, Projected to Reach USD 790 Million by 2034
Anti-neurofilament L antibodies play a crucial role in detecting and monitoring neurodegenerative diseases, including Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis ...
FMIBlog2d
Global Acute Migraine Treatment Market Poised to Reach USD 4,194.1 Million by 2034 Amid Growing Awareness and Diagnosis | FMI
The global market for acute migraine treatment is on a steady growth trajectory, with sales expected to rise from USD 2,700.7 million in 2024 to USD 4,194.1 million by 2034, reflecting a CAGR of 4.5% ...
NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
Submission for New Intended Use That Leverages Company’s Patented OneRF® Technology Platform Expected in May 2025 EDEN PRAIRIE, Minn., March 11, ...
Investing15d
Alzamend Neuro inks deal for equity securities sale
Alzamend Neuro , Inc. (NASDAQ:ALZN), a biopharmaceutical company specializing ... Stock for an equal number of Series C Convertible Preferred Stock, along with the sale of up to 500 shares of Series C ...
Investing15d
Alzamend Neuro inks deal for equity securities sale
Alzamend Neuro , Inc. (NASDAQ ... for an equal number of Series C Convertible Preferred Stock, along with the sale of up to 500 shares of Series C Preferred Stock and corresponding warrants ...